trolamine salicylate has been researched along with Alveolar Bone Atrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebbers, M; Engelmann, R; Hieke, C; Kreikemeyer, B; Kriebel, K; Lang, H; Lübcke, PM; Müller-Hilke, B; Volzke, J | 1 |
| da Silva, TA; de Oliveira, CR; Ferreira, AJ; Fukada, SY; Madeira, MF; Moura, AP; Queiroz-Junior, CM; Silveira, KD; Soriani, FM; Souza, DG; Teixeira, MM | 1 |
2 other study(ies) available for trolamine salicylate and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Interplay between P. gingivalis, F. nucleatum and A. actinomycetemcomitans in murine alveolar bone loss, arthritis onset and progression.
Topics: Actinobacteria; Alveolar Bone Loss; Animals; Antibodies, Bacterial; Arthritis; Arthritis, Experimental; Disease Models, Animal; Disease Progression; Disease Susceptibility; Fusobacterium nucleatum; Mice; Periodontitis; Porphyromonas gingivalis | 2018 |
Protective effects of the angiotensin type 1 receptor antagonist losartan in infection-induced and arthritis-associated alveolar bone loss.
Topics: Aggregatibacter actinomycetemcomitans; Alveolar Bone Loss; Animals; Anti-Inflammatory Agents; Arthritis; Histocytochemistry; Knee Joint; Losartan; Male; Maxilla; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pasteurellaceae Infections; RAW 264.7 Cells; Receptor, Angiotensin, Type 1; Serum | 2015 |